Diagnostic Imaging's Weekly Scan: November 23 — November 29

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In a recent interview with Diagnostic Imaging, Nina Kottler, M.D., discussed key trends that are leading to a renewed focus on improved enterprise imaging platforms and the potential promise of integrating Cognita Imaging’s Mosaic Drafting vision language model technology into the MosaicOS platform.

In MRI findings to be presented at the upcoming RSNA meeting, researchers demonstrated that the combination of higher muscle mass and lower visceral fat may have an impact on brain aging.

In another interview with Diagnostic Imaging, Shadpour Demehri, M.D. and Elena Ghotbi, M.D., discussed their recent study that suggests that deep learning assessment of the adrenal volume index (AVI) from chest CT exams may provide an objective biomarker of chronic stress,

The recent launch of the AI-powered TrackPSMA reportedly facilitates improved efficiency in the monitoring of PSMA PET/CT scans to help determine the effectiveness of radioligand therapy in patients with prostate cancer and may allow more timely decisions to adjust treatment dosage or switch to a more effective modality.

Earlier this week, RapidAI received four new FDA clearances for CT-based AI modules, including Rapid LMVO, which facilitates assessment of ischemic stroke, and Rapid MLS, which aids in the quantification of midline shifts with potential brain injuries.

Watch the video summary below of Diagnostic Imaging’s Weekly Scan.